206 related articles for article (PubMed ID: 37272060)
1. Hybrid-seq deciphers the complex transcriptional profile of the human
Adamopoulos PG; Athanasopoulou K; Boti MA; Dimitroulis G; Daneva GN; Tsiakanikas P; Scorilas A
RNA Biol; 2023 Jan; 20(1):281-295. PubMed ID: 37272060
[TBL] [Abstract][Full Text] [Related]
2. BRCA1, a 'complex' protein involved in the maintenance of genomic stability.
Savage KI; Harkin DP
FEBS J; 2015 Feb; 282(4):630-46. PubMed ID: 25400280
[TBL] [Abstract][Full Text] [Related]
3. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.
Ha KC; Lalonde E; Li L; Cavallone L; Natrajan R; Lambros MB; Mitsopoulos C; Hakas J; Kozarewa I; Fenwick K; Lord CJ; Ashworth A; Vincent-Salomon A; Basik M; Reis-Filho JS; Majewski J; Foulkes WD
BMC Med Genomics; 2011 Oct; 4():75. PubMed ID: 22032724
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins.
Maniccia AW; Lewis C; Begum N; Xu J; Cui J; Chipitsyna G; Aysola K; Reddy V; Bhat G; Fujimura Y; Henderson B; Reddy ES; Rao VN
J Cell Physiol; 2009 Jun; 219(3):634-41. PubMed ID: 19170108
[TBL] [Abstract][Full Text] [Related]
5. The BRCA1 alternative splicing variant Δ14-15 with an in-frame deletion of part of the regulatory serine-containing domain (SCD) impairs the DNA repair capacity in MCF-7 cells.
Sevcik J; Falk M; Kleiblova P; Lhota F; Stefancikova L; Janatova M; Weiterova L; Lukasova E; Kozubek S; Pohlreich P; Kleibl Z
Cell Signal; 2012 May; 24(5):1023-30. PubMed ID: 22245140
[TBL] [Abstract][Full Text] [Related]
6. Expression of BRCA1, NBR1 and NBR2 genes in human breast cancer cells.
Dimitrov SD; Matousková E; Forejt J
Folia Biol (Praha); 2001; 47(4):120-7. PubMed ID: 11508855
[TBL] [Abstract][Full Text] [Related]
7. Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stability.
Savage KI; Gorski JJ; Barros EM; Irwin GW; Manti L; Powell AJ; Pellagatti A; Lukashchuk N; McCance DJ; McCluggage WG; Schettino G; Salto-Tellez M; Boultwood J; Richard DJ; McDade SS; Harkin DP
Mol Cell; 2014 May; 54(3):445-59. PubMed ID: 24746700
[TBL] [Abstract][Full Text] [Related]
8. Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events.
de Jong LC; Cree S; Lattimore V; Wiggins GAR; Spurdle AB; ; Miller A; Kennedy MA; Walker LC
Breast Cancer Res; 2017 Nov; 19(1):127. PubMed ID: 29183387
[TBL] [Abstract][Full Text] [Related]
9. Cloning and functional identification of two novel BRCA1 splicing variants.
Miao L; Cao Z; Shen C; Gu M; Liu W; Li H; Zheng C
Biochemistry (Mosc); 2008 Nov; 73(11):1214-23. PubMed ID: 19120025
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium.
Colombo M; Blok MJ; Whiley P; Santamariña M; Gutiérrez-Enríquez S; Romero A; Garre P; Becker A; Smith LD; De Vecchi G; Brandão RD; Tserpelis D; Brown M; Blanco A; Bonache S; Menéndez M; Houdayer C; Foglia C; Fackenthal JD; Baralle D; Wappenschmidt B; ; Díaz-Rubio E; Caldés T; Walker L; Díez O; Vega A; Spurdle AB; Radice P; De La Hoya M
Hum Mol Genet; 2014 Jul; 23(14):3666-80. PubMed ID: 24569164
[TBL] [Abstract][Full Text] [Related]
11. Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.
Brandão RD; Mensaert K; López-Perolio I; Tserpelis D; Xenakis M; Lattimore V; Walker LC; Kvist A; Vega A; Gutiérrez-Enríquez S; Díez O; ; de la Hoya M; Spurdle AB; De Meyer T; Blok MJ
Int J Cancer; 2019 Jul; 145(2):401-414. PubMed ID: 30623411
[TBL] [Abstract][Full Text] [Related]
12. Interplay between BRCA1 and GADD45A and Its Potential for Nucleotide Excision Repair in Breast Cancer Pathogenesis.
Pietrasik S; Zajac G; Morawiec J; Soszynski M; Fila M; Blasiak J
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013256
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of breast cancer associated gene BRCA1 from breast cancer cell line.
Lixia M; Zhijian C; Chao S; Chaojiang G; Congyi Z
J Biochem Mol Biol; 2007 Jan; 40(1):15-21. PubMed ID: 17244477
[TBL] [Abstract][Full Text] [Related]
14. Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines.
Orban TI; Olah E
Biochem Biophys Res Commun; 2001 Jan; 280(1):32-8. PubMed ID: 11162473
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the BRCA1 Tumor Suppressor Network.
Jiang Q; Greenberg RA
J Biol Chem; 2015 Jul; 290(29):17724-17732. PubMed ID: 26048987
[TBL] [Abstract][Full Text] [Related]
16. Decoding the concealed transcriptional signature of the apoptosis-related BCL2 antagonist/killer 1 (BAK1) gene in human malignancies.
Athanasopoulou K; Adamopoulos PG; Daneva GN; Scorilas A
Apoptosis; 2022 Dec; 27(11-12):869-882. PubMed ID: 35876934
[TBL] [Abstract][Full Text] [Related]
17. A new alternative splice variant of BRCA1 containing an additional in-frame exon.
Fortin J; Moisan AM; Dumont M; Leblanc G; Labrie Y; Durocher F; Bessette P; Bridge P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Pichette R; Plante M; Provencher L; Voyer P; Simard J
Biochim Biophys Acta; 2005 Oct; 1731(1):57-65. PubMed ID: 16185777
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 and p53: compensatory roles in DNA repair.
Hartman AR; Ford JM
J Mol Med (Berl); 2003 Nov; 81(11):700-7. PubMed ID: 13679996
[TBL] [Abstract][Full Text] [Related]
19. Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women.
Sepahi I; Faust U; Sturm M; Bosse K; Kehrer M; Heinrich T; Grundman-Hauser K; Bauer P; Ossowski S; Susak H; Varon R; Schröck E; Niederacher D; Auber B; Sutter C; Arnold N; Hahnen E; Dworniczak B; Wang-Gorke S; Gehrig A; Weber BHF; Engel C; Lemke JR; Hartkopf A; Nguyen HP; Riess O; Schroeder C
BMC Cancer; 2019 Aug; 19(1):787. PubMed ID: 31395037
[TBL] [Abstract][Full Text] [Related]
20. Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression.
Valenti F; Ganci F; Fontemaggi G; Sacconi A; Strano S; Blandino G; Di Agostino S
Oncotarget; 2015 Mar; 6(8):5547-66. PubMed ID: 25650659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
